凝固第VIII因子の中国市場(現状と見通し)

【英語タイトル】2017-2022 China Human Coagulation Factor VIII Market Report (Status and Outlook)

LP Informationが出版した調査資料(LPI705338)・商品コード:LPI705338
・発行会社(調査会社):LP Information
・発行日:2017年5月1日
・ページ数:111
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:中国
・産業分野:化学
◆販売価格オプション(消費税別)
Single UserUSD3,360 ⇒換算¥349,440見積依頼/購入/質問フォーム
Corporate UserUSD6,720 ⇒換算¥698,880見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

The Human Coagulation Factor VIII market size will be XX million (USD) in 2022 in China, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022.
In China market, the top players include many company. With key sales data like sales (volume), revenue, market share for top players.such as
Baxter
Bayer
CSL
Pfizer
Grifols
Biogen
Octapharma
NovoNordisk
Greencross
Kedrion
BPL
Hualan Bio
RAAS

Split by product types/category, covering many types. with sales, revenue and market share for each type, such as
Recombinant Factor VIII
Plasma-derived Factor VIII

Split by applications/end use industries, covers many application. This report focuses on sales, market share and growth rate of Human Coagulation Factor VIII in each application.suach as
Hemophilia A
Spontanous / Trauma
Surgical
Other

【レポートの目次】

Table of Contents

2017-2022 China Human Coagulation Factor VIII Market Report (Status and Outlook)
1 Human Coagulation Factor VIII Market Overview
1.1 Product Overview and Scope of Human Coagulation Factor VIII
1.2 Human Coagulation Factor VIII Market Segment by Types
1.2.1 China Human Coagulation Factor VIII Sales Present Situation and Outlook by Types (2012-2022)
1.2.2 China Human Coagulation Factor VIII Sales Market Share by Types in 2016
1.2.3 Recombinant Factor VIII
Plasma-derived Factor VIII
1.3 China Human Coagulation Factor VIII Market Segment by Applications/End Use Industries
1.3.1 China Human Coagulation Factor VIII Sales Present Situation and Outlook by Applications/End Industrials (2012-2022)
1.3.2 China Human Coagulation Factor VIII Sales Market Share by Types in 2016
1.3.3 Hemophilia A
1.3.4 Spontanous / Trauma
1.3.5 Surgical
Other
1.4 China Human Coagulation Factor VIII Overview and Market Size (Value) (2012-2022)
1.4.1 China Market Human Coagulation Factor VIII Overview
1.4.2 China Human Coagulation Factor VIII Market Size (Value and Volume) Status and Forecast (2012-2022)
2 China Human Coagulation Factor VIII Sales, Revenue (Value) and Market Share by Vendors/Manufacturers
2.1 China Human Coagulation Factor VIII Sales and Market Share (2012-2017) by Vendors/Manufacturers
2.2 China Human Coagulation Factor VIII Revenue and Market Share by Vendors (2012-2017)
2.3 China Human Coagulation Factor VIII Average Price by Vendors in 2016
2.4 China Human Coagulation Factor VIII Manufacturing Base Distribution, Sales Area, Product Types by Vendors
2.5 Human Coagulation Factor VIII Market Competitive Situation and Trends
2.5.1 Human Coagulation Factor VIII Market Concentration Rate
2.5.2 Human Coagulation Factor VIII Market Share of Top 3 and Top 5 Vendors
2.5.3 Mergers & Acquisitions, Expansion
3 China Human Coagulation Factor VIII Sales, Revenue (Value) by Type and Application (2012-2017)
3.1 China Human Coagulation Factor VIII Sales, Revenue, Market Share and Price by Type (2012-2017)
3.1.1 China Human Coagulation Factor VIII Sales and Market Share by Type (2012-2017)
3.1.2 China Human Coagulation Factor VIII Revenue and Market Share by Type (2012-2017)
3.1.3 China Human Coagulation Factor VIII Price by Type (2012-2017)
3.2 China Human Coagulation Factor VIII Sales and Market Share by Application (2012-2017)
3.3 China Market Human Coagulation Factor VIII Sales, Revenue (Million USD), Price and Gross Margin (2012-2017)
4 China Human Coagulation Factor VIII Vendors/Manufacturers Profiles and Sales Data
4.1 Baxter
4.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.1.2 Human Coagulation Factor VIII Product Types, Application and Specification
4.1.2.1 Category One
4.1.2.2 Category Two
4.1.3 Baxter Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2015 and 2016)
4.1.4 Main Business/Business Overview
4.1.5 Baxter News
4.2 Bayer
4.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.2.2 Human Coagulation Factor VIII Product Types, Application and Specification
4.2.2.1 Category One
4.2.2.2 Category Two
4.2.3 Bayer Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2015 and 2016)
4.2.4 Main Business/Business Overview
4.2.5 Bayer News
4.3 CSL
4.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.3.2 Human Coagulation Factor VIII Product Types, Application and Specification
4.3.2.1 Category One
4.3.2.2 Category Two
4.3.3 CSL Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2015 and 2016)
4.3.4 Main Business/Business Overview
4.3.5 CSL News
4.4 Pfizer
4.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.4.2 Human Coagulation Factor VIII Product Types, Application and Specification
4.4.2.1 Category One
4.4.2.2 Category Two
4.4.3 Pfizer Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2015 and 2016)
4.4.4 Main Business/Business Overview
4.4.5 Pfizer News
4.5 Grifols
4.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.5.2 Human Coagulation Factor VIII Product Types, Application and Specification
4.5.2.1 Category One
4.5.2.2 Category Two
4.5.3 Grifols Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2015 and 2016)
4.5.4 Main Business/Business Overview
4.5.5 Grifols News
4.6 Biogen
4.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.6.2 Human Coagulation Factor VIII Product Types, Application and Specification
4.6.2.1 Category One
4.6.2.2 Category Two
4.6.3 Biogen Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2015 and 2016)
4.6.4 Main Business/Business Overview
4.6.5 Biogen News
4.7 Octapharma
4.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.7.2 Human Coagulation Factor VIII Product Types, Application and Specification
4.7.2.1 Category One
4.7.2.2 Category Two
4.7.3 Octapharma Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2015 and 2016)
4.7.4 Main Business/Business Overview
4.7.5 Octapharma News
4.8 NovoNordisk
4.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.8.2 Human Coagulation Factor VIII Product Types, Application and Specification
4.8.2.1 Category One
4.8.2.2 Category Two
4.8.3 NovoNordisk Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2015 and 2016)
4.8.4 Main Business/Business Overview
4.8.5 NovoNordisk News
4.9 Greencross
4.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.9.2 Human Coagulation Factor VIII Product Types, Application and Specification
4.9.2.1 Category One
4.9.2.2 Category Two
4.9.3 Greencross Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2015 and 2016)
4.9.4 Main Business/Business Overview
4.9.5 Greencross News
4.10 Kedrion
4.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.10.2 Human Coagulation Factor VIII Product Types, Application and Specification
4.10.2.1 Category One
4.10.2.2 Category Two
4.10.3 Kedrion Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2015 and 2016)
4.10.4 Main Business/Business Overview
4.10.5 Kedrion News
4.11 BPL
4.11.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.11.2 Human Coagulation Factor VIII Product Types, Application and Specification
4.11.2.1 Category One
4.11.2.2 Category Two
4.11.3 BPL Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2015 and 2016)
4.11.4 Main Business/Business Overview
4.11.5 BPL News
4.12 Hualan Bio
4.12.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.12.2 Human Coagulation Factor VIII Product Types, Application and Specification
4.12.2.1 Category One
4.12.2.2 Category Two
4.12.3 Hualan Bio Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2015 and 2016)
4.12.4 Main Business/Business Overview
4.12.5 Hualan Bio News
4.13 RAAS
4.13.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.13.2 Human Coagulation Factor VIII Product Types, Application and Specification
4.13.2.1 Category One
4.13.2.2 Category Two
4.13.3 RAAS Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2015 and 2016)
4.13.4 Main Business/Business Overview
4.13.5 RAAS News
5 Production Cost Analysis of Human Coagulation Factor VIII
5.1 Main Raw Materials of Human Coagulation Factor VIII
5.1.1 List of Human Coagulation Factor VIII Main Raw Materials
5.1.2 Human Coagulation Factor VIII Main Raw Materials Price Analysis
5.1.3 Human Coagulation Factor VIII Raw Materials Major Suppliers
5.1.4 Human Coagulation Factor VIII Main Raw Materials Market Concentration Rate
5.2 Production Cost Structure of Human Coagulation Factor VIII
5.2.1 Raw Materials
5.2.2 Labor Cost
5.2.3 Production Expenses
5.3 Human Coagulation Factor VIII Manufacturing Process/Method
6 Value Chain, Purchasing Strategy and Downstream Buyers
6.1 Human Coagulation Factor VIII Value Chain Analysis
6.2 Upstream Raw Materials Purchasing
6.3 Raw Materials Sources of Human Coagulation Factor VIII Major Vendors in 2016
6.4 Downstream Buyers
7 Marketing Strategy Analysis, Distributors/Traders
7.1 Sales Channel
7.1.1 Direct Sales
7.1.2 Indirect Sales
7.1.3 Sales Channel Development Trend
7.2 Product Market Positioning
7.2.1 Pricing Strategy
7.2.2 Brand Strategy
7.2.3 Target Client
7.3 Human Coagulation Factor VIII Distributors/Traders List in China
8 Market Influences Factors Analysis
8.1 Changes from the Related Industries
8.2 Substitutes Threat
8.3 Customer Preference Change
8.4 Economic/Political Environmental Change
8.5 Upstream and Downstream Fluctuation
9 China Human Coagulation Factor VIII Market Forecast (2017-2022)
9.1 China Human Coagulation Factor VIII Sales, Revenue and Price Forecast (2017-2022)
9.1.1 China Human Coagulation Factor VIII Sales and Growth Rate Forecast (2017-2022)
9.1.2 China Human Coagulation Factor VIII Revenue and Growth Rate Forecast (2017-2022)
9.1.3 China Human Coagulation Factor VIII Price Trend Forecast (2017-2022)
9.2 China Human Coagulation Factor VIII Sales Forecast by Type (2017-2022)
9.3 China Human Coagulation Factor VIII Sales Forecast by Application (2017-2022)
10 Research Findings and Conclusion
11 Appendix
11.1 Methodology
11.2 Analyst Introduction
11.3 Data Source

List of Tables and Figures

Figure Picture of Human Coagulation Factor VIII
Figure China Human Coagulation Factor VIII Sales (volume) for Each Type (2012-2022)
Figure China Human Coagulation Factor VIII Sales Market Share by Types in 2016
Figure Product Picture of Recombinant Factor VIII
Table Major Players of Recombinant Factor VIII
Figure Product Picture of Plasma-derived Factor VIII
Table Major Players of Plasma-derived Factor VIII
Figure China Human Coagulation Factor VIII Sales Present Situation and Outlook by Applications (2012-2022)
Figure China Human Coagulation Factor VIII Sales Market Share by Types in 2016
Figure Hemophilia A Examples
Figure Spontanous / Trauma Examples
Figure Surgical Examples
Figure Other Examples
Figure China Human Coagulation Factor VIII Revenue (Million USD) Status and Forecast (2012-2022)
Figure China Human Coagulation Factor VIII Sales (Volume) Status and Forecast (2012-2022)
Table China Human Coagulation Factor VIII Sales by Vendors (2012-2017)
Table China Human Coagulation Factor VIII Sales Market Share (%) by Vendors (2012-2017)
Figure China Human Coagulation Factor VIII Sales Share by Vendors in 2015
Figure China Human Coagulation Factor VIII Sales Share by Vendors in 2016
Table China Human Coagulation Factor VIII Revenue (Million USD) by Vendors (2012-2017)
Table China Human Coagulation Factor VIII Revenue Market Share (%) by Vendors (2012-2017)
Figure China Human Coagulation Factor VIII Revenue Share by Vendors in 2015
Figure China Human Coagulation Factor VIII Revenue Share by Vendors in 2016
Table China Human Coagulation Factor VIII Average Price by Vendors in 2016
Table China Human Coagulation Factor VIII Manufacturing Base Distribution and Sales Area by Vendors
Table Vendors Human Coagulation Factor VIII Product Types
Figure Human Coagulation Factor VIII Market Share of Top 3 Vendors
Figure Human Coagulation Factor VIII Market Share of Top 5 Vendors
Table China Human Coagulation Factor VIII Sales by Type (2012-2017)
Table China Human Coagulation Factor VIII Sales and Market Share by Type (2012-2017)
Figure China Human Coagulation Factor VIII Sales Market Share by Type (2012-2017)
Figure 2016 China Human Coagulation Factor VIII Sales Market Share by Type
Table China Human Coagulation Factor VIII Revenue (Million USD) by Type (2012-2017)
Table China Human Coagulation Factor VIII Revenue Market Share by Type (2012-2017)
Figure China Human Coagulation Factor VIII Revenue Market Share by Type (2012-2017)
Figure 2016 China Human Coagulation Factor VIII Revenue Market Share by Type
Table China Human Coagulation Factor VIII Price by Type (2012-2017)
Table China Human Coagulation Factor VIII Sales by Application (2012-2017)
Table China Human Coagulation Factor VIII Sales and Market Share by Application (2012-2017)
Figure China Human Coagulation Factor VIII Sales Market Share by Application (2012-2017)
Figure 2016 China Human Coagulation Factor VIII Sales Market Share by Application
Table China Market Human Coagulation Factor VIII Sales, Revenue (Million USD), Price and Gross Margin (2012-2017)
Table Baxter Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Baxter Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Baxter Human Coagulation Factor VIII Market Share (2012-2017)
Table Bayer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bayer Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Bayer Human Coagulation Factor VIII Market Share (2012-2017)
Table CSL Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table CSL Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2012-2017)
Figure CSL Human Coagulation Factor VIII Market Share (2012-2017)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Pfizer Human Coagulation Factor VIII Market Share (2012-2017)
Table Grifols Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Grifols Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Grifols Human Coagulation Factor VIII Market Share (2012-2017)
Table Biogen Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Biogen Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Biogen Human Coagulation Factor VIII Market Share (2012-2017)
Table Octapharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Octapharma Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Octapharma Human Coagulation Factor VIII Market Share (2012-2017)
Table NovoNordisk Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table NovoNordisk Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2012-2017)
Figure NovoNordisk Human Coagulation Factor VIII Market Share (2012-2017)
Table Greencross Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Greencross Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Greencross Human Coagulation Factor VIII Market Share (2012-2017)
Table Kedrion Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Kedrion Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Kedrion Human Coagulation Factor VIII Market Share (2012-2017)
Table BPL Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table BPL Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2012-2017)
Figure BPL Human Coagulation Factor VIII Market Share (2012-2017)
Table Hualan Bio Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Hualan Bio Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Hualan Bio Human Coagulation Factor VIII Market Share (2012-2017)
Table RAAS Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table RAAS Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2012-2017)
Figure RAAS Human Coagulation Factor VIII Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Human Coagulation Factor VIII Main Raw Materials Price Trend
Table Human Coagulation Factor VIII Raw Materials Major Suppliers List
Figure Production Cost Structure of Human Coagulation Factor VIII
Figure Human Coagulation Factor VIII Manufacturing Process/Method
Figure Human Coagulation Factor VIII Value Chain Analysis
Table Raw Materials Sources of Human Coagulation Factor VIII Major Vendors in 2016
Table Major Buyers of Human Coagulation Factor VIII
Table Human Coagulation Factor VIII Distributors/Traders List in China
Figure China Human Coagulation Factor VIII Sales and Growth Rate Forecast (2017-2022)
Figure China Human Coagulation Factor VIII Revenue and Growth Rate Forecast (2017-2022)
Figure China Human Coagulation Factor VIII Price Trend Forecast (2017-2022)
Table China Human Coagulation Factor VIII Sales Forecast by Type (2017-2022)
Figure China Human Coagulation Factor VIII Sales Market Share Forecast by Type (2017-2022)
Figure China Human Coagulation Factor VIII Sales Market Share Forecast by Type in 2022
Table China Human Coagulation Factor VIII Sales Forecast by Application (2017-2022)
Figure China Human Coagulation Factor VIII Sales Market Share Forecast by Application (2017-2022)
Figure China Human Coagulation Factor VIII Sales Market Share Forecast by Application in 2022

★調査レポート[凝固第VIII因子の中国市場(現状と見通し)] (コード:LPI705338)販売に関する免責事項を必ずご確認ください。
★調査レポート[凝固第VIII因子の中国市場(現状と見通し)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆